Clinical Trials Directory

Trials / Completed

CompletedNCT06213740

Validation of a New Simplified Scoring System for Acute Calculous Cholecystitis

Validation of a New Simplified Scoring System (ACME) for Acute Calculous Cholecystitis

Status
Completed
Phase
Study type
Observational
Enrollment
387 (actual)
Sponsor
Hospital del Mar · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Acute calculous cholecystitis (ACC) is the second most frequent surgical condition in emergency departments. The recommended treatment is surgical treatment (ST) and the accepted mortality is \<1%, but in severe and/or fragile patients is higher. Despite the Tokyo Guidelines, there no consensus on who is the unfit patient for ST. A recent study has identified 4 risk factors that predicts the mortality in a 92% of patients (ACME) and could help to develop new guidelines in ACC. The aim of this study is this validation of the new simplified scoring system for mortality in ACC.

Detailed description

This is a retrospective single-center observational study of 387 adults with ACC during 2 non-consecutive years (2017/2021), including baseline demographic characteristics, comorbidity severity defined as Charlson Comorbidity Index (CCI), ASA Score, Tokyo Guidelines' severity classification and the new ACME Score. The primary outcome is to study the prediction of mortality of ACME score. Secondary outcomes include complications following Clavien-Dindo's classification, C-statistic, and ROC Curves.

Conditions

Timeline

Start date
2021-01-08
Primary completion
2021-05-01
Completion
2021-12-17
First posted
2024-01-19
Last updated
2024-01-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06213740. Inclusion in this directory is not an endorsement.

Validation of a New Simplified Scoring System for Acute Calculous Cholecystitis (NCT06213740) · Clinical Trials Directory